Chemical shift assignments and structure of the alpha-crystallin domain from human, HSPB5
SOLUTION NMR
| NMR Experiment | ||||||||
|---|---|---|---|---|---|---|---|---|
| Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
| 1 | 2D 1H-15N HSQC | 0.6 mM [U-100% 13C; U-100% 15N] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF | 90% H2O/10% D2O | 100 | 7.5 | ambient | 295 | |
| 2 | 2D 1H-15N HSQC | 0.6 mM [U-100% 13C; U-100% 15N; U-80% 2H] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF | 90% H2O/10% D2O | 100 | 6.5 | ambient | 295 | |
| 3 | 2D 1H-15N HSQC | 0.6 mM [U-100% 13C; U-100% 15N; U-80% 2H] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF | 90% H2O/10% D2O | 100 | 7.5 | ambient | 295 | |
| 4 | 3D 1H-15N NOESY | 0.6 mM [U-100% 13C; U-100% 15N] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF | 90% H2O/10% D2O | 100 | 7.5 | ambient | 295 | |
| 5 | 2D 1H-13C HSQC aliphatic | 1.0 mM [U-100% 13C; U-100% 15N] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF | 100% D2O | 100 | 7.5 | ambient | 295 | |
| 6 | 2D 1H-13C HSQC aromatic | 1.0 mM [U-100% 13C; U-100% 15N] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF | 100% D2O | 100 | 7.5 | ambient | 295 | |
| 7 | 3D HNCACB | 0.6 mM [U-100% 13C; U-100% 15N; U-80% 2H] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF | 90% H2O/10% D2O | 100 | 7.5 | ambient | 295 | |
| 8 | 3D HBHA(CO)NH | 0.6 mM [U-100% 13C; U-100% 15N; U-80% 2H] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF | 90% H2O/10% D2O | 100 | 7.5 | ambient | 295 | |
| 9 | 3D HNCO | 0.6 mM [U-100% 13C; U-100% 15N; U-80% 2H] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF | 90% H2O/10% D2O | 100 | 7.5 | ambient | 295 | |
| 10 | 3D HNCA | 0.6 mM [U-100% 13C; U-100% 15N; U-80% 2H] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF | 90% H2O/10% D2O | 100 | 7.5 | ambient | 295 | |
| 11 | 3D HN(CO)CA | 0.6 mM [U-100% 13C; U-100% 15N; U-80% 2H] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF | 90% H2O/10% D2O | 100 | 7.5 | ambient | 295 | |
| 12 | 3D HN(COCA)CB | 0.6 mM [U-100% 13C; U-100% 15N; U-80% 2H] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF | 90% H2O/10% D2O | 100 | 7.5 | ambient | 295 | |
| 13 | 3D HCCH-TOCSY | 1.0 mM [U-100% 13C; U-100% 15N] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF | 100% D2O | 100 | 7.5 | ambient | 295 | |
| 14 | 3D H(CCO)NH | 1.0 mM [U-100% 13C; U-100% 15N; 50% 2H] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF | 90% H2O/10% D2O | 100 | 7.5 | ambient | 295 | |
| 15 | 3D C(CO)NH | 1.0 mM [U-100% 13C; U-100% 15N; 50% 2H] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF | 90% H2O/10% D2O | 100 | 7.5 | ambient | 295 | |
| NMR Spectrometer Information | |||
|---|---|---|---|
| Spectrometer | Manufacturer | Model | Field Strength |
| 1 | Bruker | AVANCE | 800 |
| 2 | Bruker | AVANCE | 600 |
| 3 | Bruker | AVANCE | 500 |
| 4 | Bruker | AVANCE | 900 |
| NMR Refinement | ||
|---|---|---|
| Method | Details | Software |
| simulated annealing | NMRPipe | |
| NMR Ensemble Information | |
|---|---|
| Conformer Selection Criteria | structures with the lowest energy |
| Conformers Calculated Total Number | 100 |
| Conformers Submitted Total Number | 9 |
| Representative Model | 1 (closest to the average) |
| Additional NMR Experimental Information | |
|---|---|
| Details | Solution structure was determined with NOEs and RDCs. |
| Computation: NMR Software | ||||
|---|---|---|---|---|
| # | Classification | Version | Software Name | Author |
| 1 | data analysis | NMRPipe | Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax | |
| 2 | processing | NMRPipe | Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax | |
| 3 | peak picking | NMRPipe | Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax | |
| 4 | data analysis | NMRView | Johnson, One Moon Scientific | |
| 5 | chemical shift assignment | NMRView | Johnson, One Moon Scientific | |
| 6 | peak picking | NMRView | Johnson, One Moon Scientific | |
| 7 | chemical shift assignment | AutoAssign | Zimmerman, Moseley, Kulikowski and Montelione | |
| 8 | peak picking | AutoAssign | Zimmerman, Moseley, Kulikowski and Montelione | |
| 9 | structure solution | CS-ROSETTA | Shen, Vernon, Baker and Bax | |
| 10 | chemical shift assignment | CS-ROSETTA | Shen, Vernon, Baker and Bax | |
| 11 | peak picking | CS-ROSETTA | Shen, Vernon, Baker and Bax | |
| 12 | structure solution | RosettaOligomer | (RosettaOligomer)-Sgourakis, Lange, DiMaio, Andre, Fitzkee, Rossi, Montelione, Bax, Baker | |
| 13 | chemical shift assignment | RosettaOligomer | (RosettaOligomer)-Sgourakis, Lange, DiMaio, Andre, Fitzkee, Rossi, Montelione, Bax, Baker | |
| 14 | peak picking | RosettaOligomer | (RosettaOligomer)-Sgourakis, Lange, DiMaio, Andre, Fitzkee, Rossi, Montelione, Bax, Baker | |
| 15 | refinement | TALOS | Cornilescu, Delaglio and Bax | |
| 16 | chemical shift assignment | TALOS | Cornilescu, Delaglio and Bax | |
| 17 | peak picking | TALOS | Cornilescu, Delaglio and Bax | |
| 18 | data analysis | GUARDD | (GUARDD)-Kleckner, Foster | |
| 19 | chemical shift assignment | GUARDD | (GUARDD)-Kleckner, Foster | |
| 20 | peak picking | GUARDD | (GUARDD)-Kleckner, Foster | |
| 21 | refinement | RosettaOligomer | ||














